1-In what dosage form is Lipitor available? (Select all that apply)
Select one or more:
a. capsule
b. tablet
c. lotion
d. solution for injection
2-What is the correct initial dose of irbesartan for a 15-year-old patient with hypertension?
Select one:
a. 450mg/day
b. 300mg/day
c. 150mg/day
d. 25mg/day
3- If clonidine and desipramine are given together what drug interaction may occur?
Select one:
a. no interaction occurs
b. clonidine effects may be decreased
c. clonidine effects may be increased
d. desipramine effects may be decreased
e. desipramine effects may be increased
4-In what strength(s) is Prevacid available?
Select one:
a. 10mg
b. 20mg
c. 30mg
5-Are theophylline and linezolid compatible at the Y site?
Select one:
a. Compatible
b. Incompatible
6-What are current recommendations regarding the use of Singulair in women who are breastfeeding?
Select one:
a. It is safe for use.
b. It is not safe for use.
c. Until more information is available caution should be used.
7- The clinical study conducted by Boerner, et al and published in Phytomedicine in 2003 used a Answer blind study design.
8- Copy/paste the abstract and indexing information for a case report of phenytoin causing hepatotoxicity
A 55-year-old woman was hospitalized for treatment of community-acquired pneumonia. Unexplained, moderate elevations in hepatic transaminase and enzyme levels prompted review of her drug regimen. She had taken acetaminophen 1,300-6,200 mg/day during the hospitalization. She also received phenytoin for posttraumatic seizures. Acetaminophen was discontinued, and the patient's liver chemistries returned to normal within 2 weeks of discharge. Acetaminophen is metabolized in part by cytochrome P450 (CYP) 2E1, and inducers of CYP2E1 are known to predispose patients to acetaminophen-related hepatotoxicity. Phenytoin induces CYP2C and CYP3A4 isoforms, but not CYP2E1. The literature suggests, however, that CYP3A4 may participate in acetaminophen metabolism to a greater extent than previously realized, and induction of this isoform may predispose patients to acetaminophen-induced hepatotoxicity.
9-What is the PMID for a phase III clinical trial of zoledronic acid by M Dong published in March 2008?